Meeting ‘Cluster Cooperation across Europe’, July 13, 2011.

The meeting ‘Cluster Cooperation across Europe’ will take place on July 13th in the Genopole premises in Evry (south of Paris). This meeting is one of the Dissemination events of the EU project Bio-Common Tools-Bio-CT (Regions of Knowledge).

This meeting, hosted by the BioCT consortium and Genopole, its Coordinator, brings together key clusters in Europe to discuss and agree on how formal partnerships can be created around key biotechnology support topics ; Sharing Facilities, Technology Maturation and Developing talent.

VENUE :

Genopole GIP

5 rue Henri Desbrueres

Genopole Campus 1

91000 Evry

France

+33 (0)1 60 87 83 00

The agenda for the day includes :

Keynote presentation : The future for cluster partnerships in Europe - the need and the pathways

Plenary discussion panel : Finding maximum points of benefit for cluster partnerships

Plenary round table 1 : Sharing facilities - Presentations and discussion

Plenary round table 2 : Maturing technologies - Presentations and discussion

Plenary round table 3 : Engaging talent- Presentations and discussion

Full meeting details are available online here.

Biology. Genopole, building and coordinating a research cluster in genomics, post-genomics and related sciences

At the time of its launch in 1998, Genopole® had a three-fold mission:

• Develop a center of excellence in genomics and post-genomics research (with a special focus on gene therapy), in close collaboration with the University of Evry-Val-d’Essonne (UEVE).
• Foster the creation and development of biotech companies in the Paris Ile-de-France region by providing appropriate support.
• Create a biopark in Evry-Corbeil from the ground up, interfaced with academic research and shared-access technology platforms and services.

In collaboration with France’s national research institutes and the Paris Ile-de-France region’s universities, Genopole® hosts and equips academic research units specializing in genetics, genomics and related sciences. As of December 31, 2007, the Evry-Corbeil biopark hosted 22 academic research laboratories run by the CNRS, INSERM, CEA and INRA nation research institutes and the universities of Evry-Val d’Essonne, Paris-VII and Versailles-Saint-Quentin.

• Reinforcing a center of excellence in life science teaching and training

In collaboration with the University of Evry-Val d’Essonne, Genopole® helps to set up high-level teaching programs (notably in genomics, gene therapy and bioinformatics), reinforce joint national institute/university research groups and establish links with other French universities. Founded in July 1991, the University of Evry-Val d’Essonne (UEVE) now offers around 160 courses (of which over 80 are vocational in nature) to a total of 10,000 students. Since the start of the 2005 academic year, the UEVE has been operating the Bachelor–Master–Doctorate degree system.

• Promoting the growth of the biotech industry

By providing custom financial and technical project support, Genopole® offers entrepreneurs an opportunity to move onto a thriving life science research and business park. In addition, Genopole®’s independent Expert Committee helps life science entrepreneurs to evaluate and refine their business plans.
Company founders can also apply for funding to the Genopole 1er Jour seed fund (renamed G1J Ile-de-France in 2007). In the space of 10 years, Genopole® has hosted or fostered the creation, establishment or development of some 64 biotech companies (net total as of December 31, 2007).

© Crédits Photos : Génopole

Mapping the Paris Region economy :

Find out the Genopole on Econovista, the economic map of Paris Region

Discover all universities and public research center on Econovista, the economic map of Paris Region

Competitiveness cluster. Medicen’s performance contract

The Medicen competitiveness cluster has signed its performance contract for 2009-2011 with the aim of establishing Paris Region as a European industry leader in the spheres of diagnostic and therapeutic progress and in advanced healthcare technology.

The three major RD priorities identified in this strategy are translational medicine, biological systems for industrial use, and bio-therapeutic products and bio-digital systems (bio-IT, integration and modelling, e-healthcare, brain-machine interfaces). These priorities will be focused on the cluster’s primary research areas: cancers, neurovegetative, sensory and psychiatric disorders, and infectious diseases.

The cluster plans to establish a partnership with Systematic Paris Region to develop bio-digital systems and healthcare information technologies.

Discover the Biocluster map on Econovista, the free interactive map of Paris Region

Find Cap Digital and AsTECH two other competitiveness clusters, on Econovista, the free interactive map of Paris Region